Sign inCreate account

Report workspace tools

NCT06049901UNKNOWNanonymous

Clinical Study Evaluating the Efficacy and Safety of Nitazoxanide in Patients With Metastatic Colorectal Cancer

Sponsor

Source record

Tanta University

Phase

Source record

Phase 3

Modality

AI-normalized

small molecule

Target

AI-normalized

Metastatic Colorectal Cancer

Indication / condition

AI-normalized

Metastatic Colorectal Cancer

Intervention

Source record

Nitazoxanide

Source & freshness

Source record

NCT ID

NCT06049901

Original source

ClinicalTrials.gov

Source last updated

Sep 22, 2023

Ingested at

May 30, 2026

Internal sync

Jun 05, 2026

Model version

trialsignal-ai-v1

Normalized confidence

88%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT06049901

Title

Clinical Study Evaluating the Efficacy and Safety of Nitazoxanide in Patients With Metastatic Colorectal Cancer

Sponsor

Tanta University

Status

UNKNOWN

Phase

Phase 3

Condition raw

Metastatic Colorectal Cancer

Condition normalized

Metastatic Colorectal Cancer

Modality raw

Metastatic Colorectal Cancer

Modality normalized

small molecule

Target raw

Metastatic Colorectal Cancer

Target normalized

Metastatic Colorectal Cancer

Interventions

Nitazoxanide

Public preview

Source record

This clinical trial, sponsored by Tanta University, aims to evaluate the efficacy and safety of nitazoxanide in patients with metastatic colorectal cancer. The study involves 60 participants, divided into two groups: one receiving standard chemotherapy and the other receiving chemotherapy plus nitazoxanide.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account
Sign in

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Clinical Study Evaluating the Efficacy and Safety of Nitazoxanide in Patients With Metastatic Colorectal Cancer

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 13, 2026

NCT ID

NCT06049901

Status

UNKNOWN

Phase

Phase 3

Sponsor

Tanta University

Executive brief

Investment-Ready Snapshot

This clinical trial, sponsored by Tanta University, aims to evaluate the efficacy and safety of nitazoxanide in patients with metastatic colorectal cancer. The study involves 60 participants, divided into two groups: one receiving standard chemotherapy and the other receiving chemotherapy plus nitazoxanide.

Source & freshness

Provenance

SourceClinicalTrials.gov
Source updatedSep 22, 2023
Internal syncJun 05, 2026
Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT06049901

Indication

Metastatic Colorectal Cancer

Modality

small molecule

Target

Metastatic Colorectal Cancer

Intervention

Nitazoxanide

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.